Cutler Group’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-40,913
| Closed | -$3.8M | – | 6436 |
|
|
2021
Q4 | $3.8M | Buy |
+40,913
| New | +$2.7M | 0.16% | 122 |
|
|
2021
Q3 | – | Sell |
-2,500
| Closed | -$148K | – | 6693 |
|
|
2021
Q2 | $170K | Hold |
2,500
| – | – | 0.01% | 1461 |
|
|
2021
Q1 | $173K | Sell |
2,500
-75
| -3% | -$5.77K | 0.01% | 1377 |
|
|
2020
Q4 | $197K | Buy |
2,575
+2,325
| +930% | +$174K | 0.01% | 1093 |
|
|
2020
Q3 | $18K | Buy |
+250
| New | +$16.7K | ﹤0.01% | 2554 |
|
|
2020
Q1 | – | Sell |
-1,300
| Closed | -$59K | – | 4915 |
|
|
2019
Q4 | $59K | Buy |
1,300
+800
| +160% | +$37.8K | ﹤0.01% | 1521 |
|
|
2019
Q3 | $22K | Sell |
500
-600
| -55% | -$33.7K | ﹤0.01% | 2137 |
|
|
2019
Q2 | $64K | Buy |
1,100
+100
| +10% | +$5.17K | 0.01% | 1371 |
|
|
2019
Q1 | $44K | Sell |
1,000
-4,900
| -83% | -$225K | ﹤0.01% | 1521 |
|
|
2018
Q4 | $229K | Buy |
5,900
+1,900
| +48% | +$74.6K | 0.02% | 566 |
|
|
2018
Q3 | $184K | Sell |
4,000
-1,936
| -33% | -$78.5K | 0.01% | 886 |
|
|
2018
Q2 | $258K | Sell |
5,936
-6,400
| -52% | -$275K | 0.02% | 677 |
|
|
2018
Q1 | $487K | Buy |
+12,336
| New | +$480K | 0.04% | 426 |
|
|
2017
Q4 | – | Sell |
-249
| Closed | -$7.09K | – | 6290 |
|
|
2017
Q3 | $6K | Sell |
249
-9,158
| -97% | -$210K | ﹤0.01% | 4292 |
|
|
2017
Q2 | $158K | Buy |
+9,407
| New | +$129K | 0.01% | 1470 |
|
Cutler Group's ARNA Position: Q1 2022 in Review
Cutler Group sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 40,913 shares — an estimated $3.8M sold.
Cutler Group first reported a position in ARNA in Q2 2017 and held it in 15 quarters. The position peaked at $3.8M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Cutler Group reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Cutler Group sold 40,913 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $3.8M.
- Cutler Group first reported a position in Arena Pharmaceuticals Inc in Q2 2017 and held it in 15 quarters.
- Cutler Group's Arena Pharmaceuticals Inc position peaked at $3.8M in Q4 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Cutler Group's 13F filing for Q1 2022, filed 14 Apr 2022.